Requirement of a reference measurement system for the tissue factor-induced coagulation time and the international normalized ratio

[1]  Christa Cobbaert,et al.  Metrological traceability and harmonization of medical tests: a quantum leap forward is needed to keep pace with globalization and stringent IVD-regulations in the 21st century! , 2018, Clinical chemistry and laboratory medicine.

[2]  T. Lindahl,et al.  International collaborative study for the calibration of proposed International Standards for thromboplastin, rabbit, plain, and for thromboplastin, recombinant, human, plain , 2018, Journal of Thrombosis and Haemostasis.

[3]  P. H. Petersen,et al.  Effect of coagulation factors on discrepancies in International Normalized Ratio results between instruments , 2012, Clinical chemistry and laboratory medicine.

[4]  J. Connor,et al.  Clinical decision‐making as the basis for assessing agreement between measures of the International Normalized Ratio , 2009, Journal of thrombosis and haemostasis : JTH.

[5]  A. Tripodi,et al.  International Collaborative Study for the Calibration of a Proposed International Standard for thromboplastin, human, plain , 2006, Journal of thrombosis and haemostasis : JTH.

[6]  P. Mannucci,et al.  International sensitivity index calibration of the near-patient testing prothrombin time monitor, ProTime. , 2003, American journal of clinical pathology.

[7]  P. Mannucci,et al.  Collaborative Study for the Calibration of a Proposed Reference Preparation for Thromboplastin , Human Recombinant , Plain On behalf of the Subcommittee on Control of Anticoagulation , 2017 .

[8]  P. Mannucci,et al.  A Proposed Scheme for Calibration of International Reference Preparations of Thromboplastin for the Prothrombin Time , 1995, Thrombosis and Haemostasis.

[9]  L. Poller,et al.  The Calibration of the Second Primary International Reference Preparation for Thromboplastin (Thromboplastin, Human, Plain, Coded BCT/253) , 1984, Thrombosis and Haemostasis.

[10]  A. Tripodi,et al.  Guidelines for thromboplastins and plasma used to control oral anticoagulant therapy with vitamin K antagonists , 2013 .

[11]  I. Knezevic,et al.  [Biological standardization]. , 1972, Harefuah.